Chondroitinase ABC promotes functional recovery after spinal cord injury
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The inability of axons to regenerate after a spinal cord injury in the adult mammalian central nervous system (CNS) can lead to permanent paralysis. At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs). CSPGs are inhibitory to axon growth in vitro, and regenerating axons stop at CSPG-rich regions in vivo. Removing CSPG glycosaminoglycan (GAG) chains attenuates CSPG inhibitory activity. To test the functional effects of degrading chondroitin sulphate (CS)-GAG after spinal cord injury, we delivered chondroitinase ABC (ChABC) to the lesioned dorsal columns of adult rats. We show that intrathecal treatment with ChABC degraded CS-GAG at the injury site, upregulated a regeneration-associated protein in injured neurons, and promoted regeneration of both ascending sensory projections and descending corticospinal tract axons. ChABC treatment also restored post-synaptic activity below the lesion after electrical stimulation of corticospinal neurons, and promoted functional recovery of locomotor and proprioceptive behaviours. Our results demonstrate that CSPGs are important inhibitory molecules in vivo and suggest that their manipulation will be useful for treatment of human spinal injuries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Degradation of PNNs has been shown to reactivate early life-like plasticity also in the spinal cord and fear circuitry189,190.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“In rats, iPlasticity induced either by ChABC or fluoxetine improves recovery from spinal cord lesion189,201.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“As chABC removes GAG side chains from CSPGs (Bradbury et al., 2002), these results suggest that the neuroprotective effects of PNNs may be attributed to the CS-side chains of CSPGs.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“CSPG degradation via application of chABC promoted regeneration of dorsal column axons after injury.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“but also contributed to expanded receptive fields of uninjured primary afferents (Bradbury et al., 2002; Massey et al., 2006).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803 · cited 1×
“At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs)”
BackgroundSelf-citationMcKeon, R., Schreiber, R., Rudge, J., & Silver, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-11-03398.1991 · Cited by 1,188
Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors
Bregman, B. S., Kunkel-Bagden, E., Schnell, L., Dai, H. N., Gao, D., & Schwab, M. E. (1995) · Nature · doi:10.1038/378498a0 · Cited by 716
Davies, S. J. A., Goucher, D. R., Doller, C., & Silver, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05810.1999 · Cited by 606 · cited 1×
“, and regenerating axons stop at CSPG-rich regions in vivo”
BackgroundMoon, L. D. F., Asher, R. A., Rhodes, K. E., & Fawcett, J. W. (2001) · Nature Neuroscience · doi:10.1038/87415 · Cited by 562
Self-citationFunctional regeneration of sensory axons into the adult spinal cord
Ramer, M. S., Priestley, J. V., & McMahon, S. B. (2000) · Nature · doi:10.1038/35002084 · Cited by 517
Self-citationMckeon, R. J., Höke, A., & Silver, J. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1081 · Cited by 486
Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes
Asher, R. A., Morgenstern, D. A., Fidler, P. S., Adcock, K. H., Oohira, A., Braistead, J. E., Levine, J. M., Margolis, R. U., Rogers, J. H., & Fawcett, J. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02427.2000 · Cited by 482
Self-citationMcKeon, R. J., Jurynec, M. J., & Buck, C. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10778.1999 · Cited by 480
Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury
Levine, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-08-04716.1994 · Cited by 393
Cited by
Items 901–1,000 of 1,014
Kelly, E. A., Russo, A. S., Jackson, C. D., Lamantia, C. E., & Majewska, A. K. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00369 · Cited by 48
Omoto, M., Yoshida, S., Miyashita, H., Kawakita, T., Yoshida, K., Kishino, A., Kimura, T., Shibata, S., Tsubota, K., Okano, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047716 · Cited by 48
“The use of chondroitinase may also enhance the effects of SM-345431 [39].”
BackgroundMovement rehabilitation after spinal cord injuries: Emerging concepts and future directions
Marsh, B., Astill, S. L., Utley, A., & Ichiyama, R. M. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.07.011 · Cited by 54
Perineuronal and perisynaptic extracellular matrix in the human spinal cord
Jäger, C., Lendvai, D., Seeger, G., Brückner, G., Matthews, R. T., Arendt, T., Alpár, A., & Morawski, M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.014 · Cited by 53
Materials for central nervous system regeneration: bioactive cues
Gumera, C. B., Rauck, B. M., & Wang, Y. (2011) · Journal of Materials Chemistry · doi:10.1039/c0jm04335d · Cited by 49
Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems
Sunasee, R., Adokoh, C. K., Darkwa, J., & Narain, R. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.902048 · Cited by 60
“Chondroitin sulfate (CS) glycosaminoglycans are involved in various physiological processes such as cell division, inflammation and spinal cord injury [87].”
Chondroitin Sulfate in Solution: Effects of Mono- and Divalent Salts
Horkay, F., Basser, P. J., Hecht, A., & Geissler, E. (2012) · Macromolecules · doi:10.1021/ma202693s · Cited by 48
Regulation of Myelination by Exosome Associated Retinoic Acid Release from NG2-Positive Cells
Goncalves, M. B. C. V., Wu, Y., Clarke, E. E., Grist, J., Hobbs, C., Trigo, D., Jack, J., & Corcoran, J. P. T. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2922-18.2019 · Cited by 53
“Several approaches to neutralizing CSPGs after injury have included digestion of CSPGs with the enzyme chondroitinase ABC (Moon and Fawcett, 2001; Bradbury et al., 2002), RNA interference of chain polymerization enzyme (Laabs et al., 2007), and peptide blocking of protein tyrosine phosphatase (Lang et al., 2015).”
BackgroundMethodInfluentialLuo, Y., Xu, T., Liu, W., Rong, Y., Wang, J., Fan, J., Yin, G., & Cai, W. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1734598 · Cited by 51
Memory Deficits in Aging and Neurological Diseases
Khan, Z. U., Martín‐Montañez, E., Navarro‐Lobato, I., & Muly, E. C. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-420170-5.00001-5 · Cited by 58
Spallanzani's Mouse: A Model of Restoration and Regeneration
Heber‐Katz, E., Leferovich, J. M., Bedelbaeva, K., & Gourevitch, D. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-18846-6_5 · Cited by 48
“Recent data from many laboratories have supported the idea that scar removal allows a regenerative response (Davies et al. 1999; Stichel et al. 1999; Bradbury et al. 2002; Condie and Lemons 2002).”
ResultBrazda, N., & Müller, H. W. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17518-0 · Cited by 48
Iseda, T., Nishio, T., Kawaguchi, S., Yamanoto, M., Kawasaki, T., & Wakisaka, S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.056 · Cited by 48
Yamagata, M., & Sanes, J. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1976-05.2005 · Cited by 46
Liu, W., Lee, Y., Tsai, S., Hsu, C. Y., Sun, Y., Yang, L., Tsai, S., & Yang, W. V. (2008) · Glia · doi:10.1002/glia.20706 · Cited by 49
“Specifically, recent studies have shown that axonal regeneration in the spinal cord can be promoted by degradation of CS with chondroitinase ABC (Barritt et al., 2006; Bradbury et al., 2002; Yick et al., 2003).”
BackgroundMethodInfluentialO’Brien, G. S., Martin, S. M., Söllner, C., Wright, G. J., Becker, C. G., Portera‐Cailliau, C., & Sagasti, A. (2009) · Current Biology · doi:10.1016/j.cub.2009.10.051 · Cited by 49
“Several molecular studies link functional recovery and axon regeneration following spinal cord injury to developmental plasticity in the CNS [34–38].”
BackgroundPrabhakar, V., Capila, I., Soundararajan, V., Raman, R., & Sasisekharan, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806630200 · Cited by 48
Zhiguo, F., Ji, W., Chen, S., Guoyou, Z., Chen, K., Hui, Q., Xu, W., & Zhai, X. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02051-6 · Cited by 50
Desclaux, M., Teigell, M., Amar, L., Vogel, R., Gimenez y Ribotta, M., Privat, A., & Mallet, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006227 · Cited by 46
“at neutralizing the inhibitory factors produced by the reactive astrocytes, such as chondroitin sulfate proteoglycans [48,49] and”
BackgroundSialidase, Chondroitinase ABC, and Combination Therapy after Spinal Cord Contusion Injury
Mountney, A., Zahner, M. R., Sturgill, E. R., Riley, C. J., Aston, J. W., Oudega, M., Schramm, L. P., Hurtado, A., & Schnaar, R. L. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2012.2353 · Cited by 48
“In a model of brachial plexus injury, in which we measured spinal motor axon sprouting into a peripheral nerve graft, we found equal enhancement by infused sialidase and ChABC.13 Additional stud- ies will be needed to compare sialidase and ChABC treatments in different types and severities of SCI.”
BackgroundInfluentialHarris, N. G., Nogueira, M. S. M., Verley, D. R., & Sutton, R. L. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2737 · Cited by 49
“injury to reduce the growth-inhibitory influence of CSPGs that accumulate in the developing glial scar.(1,6,8,16,20,35) We now extend”
Li, H., Wong, C. W., Li, W., Ruven, C., He, L., Wu, X., Lang, B. T., Silver, J., & Wu, W. (2015) · Scientific Reports · doi:10.1038/srep14923 · Cited by 47
Delplace, V., Pickering, A. J., Hettiaratchi, M. H., Zhao, S., Kivijärvi, T., & Shoichet, M. S. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00357 · Cited by 49
Novel innovations in cell and gene therapies for spinal cord injury
Zavvarian, M.-M., Toossi, A., Khazaei, M., Hong, J., & Fehlings, M. G. (2020) · F1000Research · doi:10.12688/f1000research.21989.1 · Cited by 49
Tsai, E. C., Krassioukov, A. V., & Tator, C. H. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.3.230 · Cited by 51
“Although we were able to obtain a modest recovery of function without specific measures designed to neutralize neurite inhibition, perhaps improved function could have been obtained with the addition of chondroitinase ABC (56) or a monoclonal antibody that neutralizes inhibitory proteins (7).”
BackgroundOlfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions
Johansson, S., Lee, I., Olson, L., & Spenger, C. (2005) · Brain · doi:10.1093/brain/awh644 · Cited by 47
“Olfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions”
Biomaterial Approaches to Modulate Reactive Astroglial Response
Zuidema, J. M., Gilbert, R. J., & Gottipati, M. K. (2018) · Cells Tissues Organs · doi:10.1159/000494667 · Cited by 46
“Since the accumulation of axon-inhibiting CSPGs occurs in the glial scar, chondroitinase ABC (chABC) was used in several studies to digest the GAG chains on CSPGs and thereby overcome CSPG-mediated inhibition [Bradbury et al., 2002; Pizzorusso et al., 2002, 2006; Barritt et al., 2006].”
BackgroundRen, Z., Chen, X., Yang, J., Kress, B. T., Tong, J., Liu, H., Takano, T., Zhao, Y., & Nedergaard, M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.010 · Cited by 48
“…et al., 1994; DeBellard et al., 1996; Schafer et al., 1996; Filbin, 2003) oligodendrocyte myelin glycoprotein (Wang et al., 2002), and chondroitin sulfate proteoglycans (CSPG) (Bradbury et al., 2002) have been intensively studied as potential mediators of the inhibitory microenvironment.”
InfluentialMatrix regulators in neural stem cell functions
Wade, A., McKinney, A., & Phillips, J. J. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.01.017 · Cited by 45
“HSPGs and CSPGs are highly expressed in the NSPC niche and they are known to modulate growth factor-mediated signaling [53, 70, 87].”
BackgroundSarveazad, A., Babahajian, A., Bakhtiari, M., Soleimani, M., Behnam, B., Yari, A., Akbari, A., Yousefifard, M., Janzadeh, A., Amini, N., et al. (2016) · Neuropeptides · doi:10.1016/j.npep.2016.07.004 · Cited by 46
“Chondroitinase ABC (ChABC) is a bacterial enzyme, which digests glycosaminoglycan (GAG) chains in CSPG (Bradbury et al., 2002).”
BackgroundAxonal regeneration in zebrafish spinal cord
Ghosh, S., & Hui, S. P. (2018) · Regeneration · doi:10.1002/reg2.99 · Cited by 52
Wu, D., Jin, Y., Shapiro, T. M., Hinduja, A., Baas, P. W., & Tom, V. J. (2020) · Nature Communications · doi:10.1038/s41467-020-19914-3 · Cited by 50
The Glial Response to Injury and Its Role in the Inhibition of CNS Repair
Fawcett, J. W. (2007) · Springer eBooks · doi:10.1007/0-387-30128-3_2 · Cited by 54
Self-citationCo-solvent mediated thermal stabilization of chondroitinase ABC I form Proteus vulgaris
Nazari‐Robati, M., Khajeh, K., Aminian, M., Fathi‐Roudsari, M., & Golestani, A. (2012) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2012.01.009 · Cited by 46
Schwann cell and olfactory ensheathing cell implantation for repair of the contused spinal cord
Oudega, M. (2007) · Acta Physiologica · doi:10.1111/j.1748-1716.2006.01658.x · Cited by 50
“In general, this can be accomplished by preventing receptor-ligand (inhibitor) binding (Schnell & Schwab 1990), by obstructing the synthesis of inhibitors (Grimpe & Silver 2004), or by degrading biologically active components of the inhibitors (Moon et al. 2001, Bradbury et al. 2002).”
BackgroundMethodRegulating axon growth within the postnatal central nervous system
Hu, F., & Strittmatter, S. M. (2004) · Seminars in Perinatology · doi:10.1053/j.semperi.2004.10.001 · Cited by 49
Marques, S. A., de Almeida, F. M., Fernandes, A. M., Souza, C. D. S., Cadilhe, D. V., Rehen, S. K., & Martinez, A. M. B. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.028 · Cited by 46
“Basic advances in CNS injury and regeneration research have led to a variety of experimental therapies, which allow effective axonal regrowth and sprouting (Bradbury et al., 2002; Reier, 2004; Arataki et al., 2005; Bradbury and McMahon, 2006; Schwab et al., 2006).”
Dermatan 4-O-sulfotransferase1 ablation accelerates peripheral nerve regeneration
Akyüz, N., Rost, S., Mehanna, A., Bian, S., Loers, G., Oezen, I., Mishra, B., Hoffmann, K., Guseva, D., Laczynska, E., et al. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.01.025 · Cited by 48
“Considering the inhibitory role of CS in neural regeneration (Asher et al., 2001; Bradbury et al., 2002), we were interested whether Chst14 deficiency altered regeneration-relevant traits of cultured glial and neuronal cells.”
Karetko-Sysa, M., Skangiel-Kramska, J., & Nowicka, D. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.05.022 · Cited by 45
“where cleavage of the CSPGs of PNNswith chondroitinaseABCpromoted functional collateral sprouting (Bradbury et al., 2002;Massey et al., 2006, Cafferty et al., 2008, for a review, see Kwok et al., 2008, Bradbury and Carter, 2011).”
Guo, X., Zahir, T., Mothe, A. J., Shoichet, M. S., Morshead, C. M., Katayama, Y., & Tator, C. H. (2012) · Cell Transplantation · doi:10.3727/096368911x612503 · Cited by 45
Cholas, R. H., Hsu, H., & Spector, M. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0577 · Cited by 50
“21,37 In most studies, the method used to deliver agents to neutralize inhibitory molecules has been by intrathecal injection.”
Ablation of Keratan Sulfate Accelerates Early Phase Pathogenesis of ALS
Hirano, K., Ohgomori, T., Kobayashi, K., Tanaka, F., Matsumoto, T., Natori, T., Matsuyama, Y., Uchimura, K., Sakamoto, K., Takeuchi, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066969 · Cited by 46
“Chondroitin sulfate (CS), a long sugar chain (named glycosaminoglycan) of proteoglycans, functions as a potent inhibitor for axonal regeneration/sprouting and synaptic plasticity [12], [13].”
BackgroundNagoshi, N., & Fehlings, M. G. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1009629 · Cited by 49
“In addition to neuroprotective therapies, neuroregenerative strategies, by using Rho protein antagonist [26,27], anti-Nogo antibody [28] and chondroitinase ABC [29], are expected to have the potential for the treatment of SCI.”
BackgroundGross, R. E., Mei, Q., Gutekunst, C., & Torre, E. R. (2007) · Cell Transplantation · doi:10.3727/000000007783464740 · Cited by 51
Inhibition and enhancement of neural regeneration by chondroitin sulfate proteoglycans
Rauvala, H., Paveliev, M., Kuja‐Panula, J., & Kulesskaya, N. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.206630 · Cited by 46
“CS chains densely deposited on the glial scar are suggested to act as major inhibitors of axon regrowth (Bradbury et al., 2002; Silver and Miller, 2004; Galtrey and Fawcett, 2007; Sharma et al., 2012).”
Comparison of subacute and chronic scar tissues after complete spinal cord transection
Li, X., Yang, B., Xiao, Z., Zhao, Y., Han, S., Yin, Y., Chen, B., & Dai, J. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.05.008 · Cited by 49
“CSPGs increase during the subacute to chronic phase after CNS injury, and studies have shown that either administration of a chondroitin sulfate (CS)-degrading enzyme, namely chondroitinase ABC (Barritt et al., 2006; Bowes et al., 2012; Bradbury and Carter, 2011; Bradbury et al., 2002; Garcia-Alias et al., 2009; Lee e…”
Astrocytes Mediate Protective Actions of Estrogenic Compounds after Traumatic Brain Injury
Martin-Jiménez, C., Gaitán-Vaca, D. M., Areiza, N., Echeverria, V., Ashraf, G. M., González, J., Sahebkar, A., Garcia-Segura, L. M., & Barreto, G. E. (2019) · Neuroendocrinology · doi:10.1159/000495078 · Cited by 46
Zhang, T., Lin, F., Liu, W., Liu, Y., Guo, Z., Xiao, C., Zhuang, X., & Chen, X. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101109 · Cited by 47
Arylsulfatase B Improves Locomotor Function after Mouse Spinal Cord Injury
Yoo, M., Khaled, M., Gibbs, K. M., Kim, J., Kowalewski, B., Dierks, T., & Schachner, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057415 · Cited by 48
“The therapeutic potential of this enzyme has been repeatedly documented to promote locomotor recovery and axonal regrowth in different types of spinal cord injury paradigms in rodents [17,30,31], not only when applied by itself, but also in combination with other conducive agents, such as neurotrophins, stem cells, an…”
Vahidi, B., Park, J. W., Kim, H. J., & Jeon, N. L. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.01.019 · Cited by 45
“Supported by revious reports (Bradbury et al., 2002; Zuo et al., 1998), these esults clearly indicate that the carbohydrate GAG side chains of SPGs are inhibitory to axonal elongation while the core protein s not.”
BackgroundSchwann cells for spinal cord repair
Oudega, M., Moon, L. D. F., & Leme, R. J. D. A. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005000600003 · Cited by 45
“, with less formation of scar tissue, it was demonstrated that the neutralization or enzymatic destruction of inhibitory molecules resulted in axonal growth across and beyond the injury/grafted area (52,56).”
BackgroundSelf-citationSpinal cord injury – scientific challenges for the unknown future
Anderberg, L., Aldskogius, H., & Holtz, A. (2007) · Upsala Journal of Medical Sciences · doi:10.3109/2000-1967-200 · Cited by 49
Lee, D.-H., Luo, X., Yungher, B. J., Bray, E. R., Lee, J. K., & Park, K. K. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1935-14.2014 · Cited by 46
“…Copyright © 2014 the authors 0270-6474/14/3415347-09$15.00/0 potent extrinsic inhibitor of axon regrowth (Davies et al., 1997; Bradbury et al., 2002; Barritt et al., 2006; Crespo et al., 2007; Kwok et al., 2008; Harris et al., 2010; Lee et al., 2010a; Jefferson et al.,…”
BackgroundInfluentialKamei, N., Kwon, S., Alev, C., Ishikawa, M., Yokoyama, A., Nakanishi, K., Yamada, K., Horii, M., Nishimura, H., Τακακι, S., et al. (2009) · Stem Cells · doi:10.1002/stem.243 · Cited by 46
Goulão, M., Ghosh, B., Urban, M. W., Sahu, M., Mercogliano, C., Charsar, B. A., Komaravolu, S., Block, C. G., Smith, G. M., Wright, M. C., et al. (2018) · Glia · doi:10.1002/glia.23555 · Cited by 49
“It is possible that these axons did not exit the lesion/graft site because the transplants were especially hospitable to the extending fibers, while the lesion–intact interface provided formidable barriers such as environmental growth inhibitors (Bradbury et al., 2002; Giger et al., 2010).”
BackgroundMothe, A. J., Coelho, M. P., Huang, L., Monnier, P. P., Cui, Y., Mueller, B. K., Jacobson, P. B., & Tator, C. H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104995 · Cited by 46
“, 2012) contribute to the inhibitory environment after SCI, and neutralization of these molecules by various means has improved recovery after SCI (Bregman et al., 1995; Bradbury et al., 2002; Dubreuil et al., 2003; Li et al., 2004).”
BackgroundTashiro, S., Nakamura, M., & Okano, H. (2022) · Cells · doi:10.3390/cells11040685 · Cited by 45
“Moreover, both perilesional and distal reactive astrocytes produce chondroitin sulfate proteoglycan (CSPG) [18].”
BackgroundGlycosaminoglycans and Glycomimetics in the Central Nervous System
Rowlands, D., Sugahara, K., & Kwok, J. C. F. (2015) · Molecules · doi:10.3390/molecules20033527 · Cited by 46
Peripheral nerve grafts after cervical spinal cord injury in adult cats
Côté, M., Hanna, A., Lemay, M. A., Ollivier-Lanvin, K., Santi, L., Miller, K., Monaghan, R., & Houlé, J. D. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.06.011 · Cited by 44
Clearing a path for nerve growth
Olson, L. (2002) · Nature · doi:10.1038/416589a · Cited by 44
Mizuno, H., Warita, H., Aoki, M., & Itoyama, Y. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21702 · Cited by 52
“…enzyme, has previously been shown to induce axonal elongation and promote functional recovery in spinal cord injury models (Moon et al., 2001; Bradbury et al., 2002) and also to create a permissive environment conducive to axonal growth from peripheral nerve graft into spinal cord (Houle et…”
BackgroundJahan, N., & Hannila, S. S. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.10.023 · Cited by 44
“(Bradbury et al., 2002; Cafferty et al., 2007; Fouad et al., 2005; Karimi-Abdolrezaee et al., 2010; Lemons et al., 1999), and this approach has produced encouraging results.”
Agudo‐Barriuso, M., Woodhoo, A., Webber, D. J., Mirsky, R., Jessen, K. R., & McMahon, S. B. (2008) · Glia · doi:10.1002/glia.20695 · Cited by 44
“To confirm a complete CST lesion, coronal sections of the lumbar spinal cord of each injured animal were labeled with an antibody against protein kinase Cg (Santa Cruz, USA) as described (Bradbury et al., 2002).”
BackgroundMethodSelf-citationTranslational spinal cord injury research
Reier, P. J., Lane, M. A., Hall, E. D., Teng, Y. D., & Howland, D. R. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52137-8.00026-7 · Cited by 50
“Studies using repeated doses through externalized or subcutaneous injectable ports avoid this issue (Bradbury et al., 2002; Tester and Howland, 2008).”
Chondroitin sulfate proteoglycans in neural development and plasticity
Maeda, N. (2010) · Frontiers in Bioscience · doi:10.2741/3637 · Cited by 44
Ramer, L. M., McPhail, L. T., Borisoff, J., Soril, L. J. J., Kaan, T. K. Y., Lee, J. H. T., Saunders, J. W. T., Hwi, L. P.-R., & Ramer, M. S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0491-07.2007 · Cited by 48
“Low-threshold cutaneous mechanosensation across the palmar surface of the forepaw was assessed using an adhesive removal test (Thallmair et al., 1998; Bradbury et al., 2002; Onifer et al., 2005; Starkey et al., 2005; Moreno-Flores et al., 2006).”
MethodChen, X.-R., Liao, S.-J., Ye, L.-X., Gong, Q., Ding, Q., Zeng, J.-S., & Yu, J. (2014) · Brain Research · doi:10.1016/j.brainres.2013.12.002 · Cited by 43
Bogen, O., Dina, O. A., Gear, R. W., & Levine, J. D. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.12.049 · Cited by 43
Jeffery, N. D., Hamilton, L., & Granger, N. P. (2011) · Veterinary Record · doi:10.1136/vr.d475 · Cited by 43
Topographically specific regeneration of sensory axons in the spinal cord
Harvey, P. A., Gong, B., Rossomando, A. J., & Frank, E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003287107 · Cited by 43
Colello, R. J., Chow, W. N., Bigbee, J. W., Lin, C., Dalton, D., Brown, D., Jha, B. S., Mathern, B. E., Lee, K. D., & Simpson, D. G. (2013) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1805 · Cited by 47
“…scar have been shown to produce and release chondroitin sulphate proteoglycans (CSPGs), proteins known to be potent inhibitors to axon regeneration (McKeon et al., 1991; Dow et al., 1993; DeWitt et al., 1994; Bradbury et al., 2002; Jones et al., 2003; Starkey et al., 2012; Alilain et al. 2011).”
BackgroundNumb rats walk – a behavioural and fMRI comparison of mild and moderate spinal cord injury
Hofstetter, C. P., Schweinhardt, P., Klason, T., Olson, L., & Spenger, C. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03062.x · Cited by 43
Proteoglycans and axon guidance: a new relationship between old partners
Masu, M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13508 · Cited by 44
Fink, K. L., Strittmatter, S. M., & Cafferty, W. B. J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3165-15.2015 · Cited by 49
“…Dimou et al., 2006; Cafferty et al., 2010; Dickendesher et al., 2012; Bartus et al., 2014) or pharmacological treatment (Schnell and Schwab, 1990; Bradbury et al., 2002; GrandPré et al., 2002; Liebscher et al., 2005; Wang et al., 2006; Wang et al., 2011; Lang et al., 2015) results in enhanced…”
BackgroundThe challenges of long-distance axon regeneration in the injured CNS
Chew, D. J., Fawcett, J. W., & Andrews, M. R. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59544-7.00013-5 · Cited by 48
Self-citationGriffin, J. M., Fackelmeier, B., Clemett, C. A., Fong, D. M., Mouravlev, A., Young, D., & O’Carroll, S. J. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113232 · Cited by 43
Mechanisms and repair strategies for white matter degeneration in CNS injury and diseases
Shahsavani, N., Kataria, H., & Karimi‐Abdolrezaee, S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166117 · Cited by 45
Molecular approaches for spinal cord injury treatment
Martinez, A. B., de Almeida, F. M., Marques, S. A., dos Santos, A. R., Prins, C. A., Cardoso, F. S. D. S., Heringer, L. D. S., & Mendonça, H. R. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.344830 · Cited by 44
“Therefore, including the combination of such therapies can favor a better axonal regeneration, reflecting in potential functional recovery after SCI (Bradbury et al., 2002; Mountney et al., 2013).”
BackgroundPetrosyan, H. A., Alessi, V., Singh, V., Hunanyan, A. S., Levine, J. M., & Arvanian, V. L. (2014) · Gene Therapy · doi:10.1038/gt.2014.74 · Cited by 44
Ishii, M., & Maeda, N. (2008) · Glycobiology · doi:10.1093/glycob/cwn040 · Cited by 42
“Furthermore, CS-PGs are considered to be a major inhibitor of axonal regeneration after injury to the central nervous system (Moon et al. 2001; Bradbury et al. 2002).”
BackgroundCheng, C.-H., Lin, C.-T., Lee, M.-J., Tsai, M., Huang, W.-H., Huang, M.-C., Lin, Y.-L., Chen, C.-J., Huang, W., & Cheng, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138705 · Cited by 46
“A number of in vivo studies have assessed the effects of ChABC treatment in rodent models with a partial spinal cord transection [15, 21, 22, 37, 38].”
BackgroundInfluentialKolb, J., Tsata, V., John, N., Kim, K., Möckel, C., Rosso, G., Kurbel, V., Parmar, A., Sharma, G., Karandasheva, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42339-7 · Cited by 49
Transcriptional profiles of mouse oligodendrocyte precursor cells across the lifespan
Heo, D., Kim, A. A., Neumann, B., Doze, V. N., Xu, Y. K. T., Mironova, Y. A., Slosberg, J., Goff, L. A., Franklin, R. J. M., & Bergles, D. E. (2025) · Nature Aging · doi:10.1038/s43587-025-00840-2 · Cited by 48
“Expression of chondroitin sulfate proteoglycans by OPCs has been shown to limit axon regrowth in the spinal cord 82 , indicating that this transformation has a critical impact on recovery processes.”
Spinal Cord Injury and the Neuron-Intrinsic Regeneration-Associated Gene Program
Fagoe, N. D., van Heest, J., & Verhaagen, J. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8329-3 · Cited by 46
“Treatment of the scar with the enzyme chondroitinase ABC, which digests CSPGs, is a promising strategy to make the scar more permissive for axon growth (GarciaAlias et al. 2008; Tester and Howland 2008; Cafferty et al. 2007; Barritt et al. 2006; Massey et al. 2006; Caggiano et al. 2005; Bradbury et al. 2002; Moon et a…”
BackgroundNeurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials
Martinez, A. M. B., Goulart, C. D. O., Ramalho, B. D. S., Oliveira, J. T., & Almeida, F. M. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i2.179 · Cited by 45
Nagai, J., Baba, R., & Ohshima, T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0005-1 · Cited by 47
“Chondroitinase ABC [66] is an enzyme for digestion of CSPG. IN-1 [140] is an antibody for Nogo-A.”
InfluentialSanthosh, K. T., Alizadeh, A., & Karimi‐Abdolrezaee, S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.06.030 · Cited by 48
Li, L., Ni, L., Eugenin, E., Heary, R., & Elkabes, S. (2019) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2019.04.010 · Cited by 33
Cell Therapeutic Strategies for Spinal Cord Injury
Zhou, P., Guan, J., Xu, P., Zhao, J., Zhang, C., Zhang, B., Mao, Y., & Cui, W. (2019) · Advances in Wound Care · doi:10.1089/wound.2019.1046 · Cited by 42
“Meanwhile, the glial scar constitutes a physical and molecular barrier at the lesion site, which forms a major impediment to axonal regeneration.(23) At present, the most common strategy for laboratory degradation of CSPG is using an enzyme called chondroitinase ABC (ChABC).”
BackgroundFunctionalized nanogel for treating activated astrocytes in spinal cord injury
Papa, S., Veneruso, V., Mauri, E., Cremonesi, G., Mingaj, X., Mariani, A., Paola, M. D., Rossetti, A., Sacchetti, A., Rossi, F., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.006 · Cited by 42
Ding, Y., Yan, Q., Ruan, J.-W., Zhang, Y.-Q., Li, W., Zeng, X., Huang, S.-F., Zhang, Y.-J., Wang, S. D., Dong, H., et al. (2010) · Cell Transplantation · doi:10.3727/096368910x528102 · Cited by 42
Role of Extracellular Factors in Axon Regeneration in the CNS: Implications for Therapy
Gervasi, N. M., Kwok, J. C. F., & Fawcett, J. W. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.6.907 · Cited by 46
Self-citationHurtado, A., Podinin, H., Oudega, M., & Grimpe, B. (2008) · Brain · doi:10.1093/brain/awn206 · Cited by 42
Sharp, K., Yee, K. M., Stiles, T. L., Aguilar, R. M., & Steward, O. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.06.023 · Cited by 47
Olfactory ensheathing cells promote corticospinal axonal outgrowth by a L1 CAM‐dependent mechanism
Witheford, M., Westendorf, K., & Roskams, A. J. (2013) · Glia · doi:10.1002/glia.22564 · Cited by 41
Cortical development and neuroplasticity in Auditory Neuropathy Spectrum Disorder
Sharma, A., & Cardon, G. J. (2015) · Hearing Research · doi:10.1016/j.heares.2015.06.001 · Cited by 44
Biomaterial strategies for limiting the impact of secondary events following spinal cord injury
Ham, T. R., & Leipzig, N. D. (2017) · Biomedical Materials · doi:10.1088/1748-605x/aa9bbb · Cited by 43
The potential of memory enhancement through modulation of perineuronal nets
Duncan, J. A., Foster, R., & Kwok, J. C. F. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14672 · Cited by 38
“…extensively in a range of experiments to investigate the effects of PNN removal on various parameters and indications including plasticity, memory, and spinal cord injury recovery (Bradbury et al., 2002; Kwok, Afshari, García‐Alías, & Fawcett, 2008; Pizzorusso et al., 2002; Romberg et al., 2013).”
BackgroundPassarelli, J. P., Nimjee, S. M., & Townsend, K. L. (2022) · Translational Stroke Research · doi:10.1007/s12975-022-01109-1 · Cited by 44
Davies, J. E., Tang, X., Bournat, J. C., & Davies, S. J. A. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.397 · Cited by 44
“…in mediating CSPG inhibition of axon growth (Properzi et al., 2005), and it has been demonstrated that enzymatic treatment of acute CNS injuries with chondroitinase ABC (Chase) to remove CSPG GAGs promotes axon growth (Moon et al., 2001; Bradbury et al., 2002; Yick et al., 2004; Chau et al., 2004).”
Metadata
- Authors
- Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B.
- Affiliations
- King's College London (GB)
- University of Cambridge (GB)
- University of London (GB)
- Corresponding author
- Bradbury, Elizabeth J.
- ORCID
- Venue
- Nature
- Published
- 2002-04
- Volume
- 416
- Issue
- 6881
- Pages
- 636-640
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2012928251
- Cited by
- 2,357
- References
- 31
- Citations by year
- 2026: 63 · 2025: 75 · 2024: 54 · 2023: 73 · 2022: 98 · 2021: 95 · 2020: 116 · 2019: 91 · 2018: 109 · 2017: 96 · 2016: 104 · 2015: 111 · 2014: 131 · 2013: 108 · 2012: 137
- FWCI
- 63.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- chondroitinase ABC, spinal cord injury, chondroitin sulfate proteoglycans, glycosaminoglycan degradation, axon regeneration, glial scar, corticospinal tract, sensory axon regeneration, locomotor recovery, proprioception, central nervous system injury
- MeSH terms
- Animals, Axons, Electrophysiology, Ganglia, Spinal, Humans, Isoenzymes, Male, Motor Activity, Nerve Crush, Nerve Regeneration, Neurons, Protein Kinase C, Psychomotor Performance, Spinal Cord Injuries, Up-Regulation, Rats, Wistar, Chondroitin ABC Lyase, GAP-43 Protein, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.